Objective: To perform a retrospective investigation of our institutional experience with salivary gland fine needle aspirations (FNA) through the framework of The Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) and assess the risks of neoplasm and malignancy for each diagnostic category. 
Society of Cytopathology and the International Academy of Cytology developed the Milan System for Reporting Salivary Gland Cytopathology (MSRSGC). 8 Similar to analogous reporting schemes, such as the Bethesda System for Reporting Thyroid Cytopathology, this classification system takes into account the ambiguities inherent to salivary gland pathology, while also risk stratifying lesions, providing a clinically useful framework for conceptualising disease. The MSRSGC is composed of seven diagnostic categories: nondiagnostic (ND), non-neoplastic (NN), atypia of undetermined significance (AUS), benign neoplasm (BN), salivary gland neoplasm of uncertain malignant potential (SUMP), suspicious for malignancy (SM) and malignant (M).
As the MSRSGC is still in its infancy, additional studies are needed to evaluate the validity of this classification system. The main objective of this study was to assess the diagnostic accuracy of salivary gland FNAs within the framework of the Milan System and evaluate the MSRSGC as a tool for risk assessment. To this end, we herein document our institutional experience with salivary gland FNAs over an 8-year period, retrospectively applying Milan System categorisations to cytological diagnoses, comparing pre-and postoperative diagnoses, and determining risks of neoplasm and malignancy.
| ME TH ODS
A retrospective audit of the electronic cytopathology database at the Hospital of the University of Pennsylvania was performed. All major and minor salivary gland FNAs obtained for diagnostic purposes at our institution over an 8-year period (January 2009 to December 2016)
were identified. The FNAs were performed by a cytopathologist or a radiologist using a direct percutaneous or transoral route with a 23-27-gauge needle. Air-dried direct smears were stained with Diff-Quik® (Polysciences, Inc. Warrington, PA, USA) for immediate on-site evaluation, and the remainder of the direct smears were Papanicolaoustained following alcohol fixation. Additional rinse material was used for ThinPrep® (Hologic, Inc. Marlborough, MA) preparation, which was also Papanicolaou-stained. A cell block, fixed in formalin and embedded in paraffin, was prepared for all cases with sufficient material. Clinical and demographic information was collected. All available followup, including repeat FNAs and/or surgical pathology specimens resulting from subsequent surgical excisions, were noted.
Final cytological diagnoses were retrospectively classified according to the MSRSGC as follows: ND, NN, AUS, BN, SUMP, SM or M.
Histological diagnoses of surgical specimens were categorised as NN, BN and M. Pre-and post-operative categorisations were compared to calculate the risk of neoplasm (RON) and risk of malignancy (ROM). In addition, the sensitivity and specificity were determined for the diagnostic categories of AUS, BN, SUMP, SM and M.
| RESULTS
Over an 8-year period (January 2009-December 2016) 893 salivary gland FNAs were performed. The mean age of patients at the time of initial FNA was 59 years (range 11-94 years). The female-to-male ratio was 1. Adenoid cystic carcinoma can be misdiagnosed as pleomorphic adenoma on cytology due to shared cellular and matrix components; the reverse is also commonly seen, particularly when hyaline or mucoid material take the shape of small hyaline globules. 16, 17 Carcinoma ex pleomorphic adenoma also poses diagnostic difficulty on FNA with sensitivity rates as low as 29% due to overlapping morphological features with other entities and issues of adequate sampling, in which the malignant component is not captured on FNA.
18,19
The cytohistological concordance rate was 98.5% for the malignant category, well above the 90% ROM suggested by the MSRSGC. 14 There was one false positive case that was a Warthin tumour on resection. For this particular case, the cytology specimen showed markedly atypical squamous cells, a few with cleared cytoplasm, in a background of necrotic and inflammatory debris. These features correlated with areas on the resection specimen where the oncocytic epithelium had undergone squamous metaplasia and demonstrated reactive atypia. It is well known that squamous or mucinous metaplasia and a dirty background in a Warthin tumour can be a diagnostic pitfall, obscuring the true nature of this benign neoplasm and leading to a misdiagnosis of squamous cell carcinoma or mucoepidermoid carcinoma. 17, 20 For the indeterminate diagnostic categories, the concordance rate was 78.9% for SM. The reported risk of malignancy in the SM category varies widely from institution to institution, ranging from 58.6% to 100%, compared to the MSRSGC target rate of 60%, probably reflective of variable institutional practices and pathologists' experiences. 14, 15, [21] [22] [23] [24] Factors contributing to an indeterminate diagnosis of SM included focal marked atypia, insufficient cellularity, a necrotic or mucinous background, or poor preservation of the aspirate. In contrast, the SUMP category had a 100% risk of neoplasm and 46.6% risk of malignancy. This ROM is higher than the 35% MSRSGC target rate 14 and close to the upper limit of the reported range in the literature, which varies from 24.1% to 50%. 15, [23] [24] [25] [26] [27] These estimates of ROM are likely to represent an overestimation of risk as they are based on cases that proceeded to surgical excision and therefore may be influenced by factors such as patient demographics, lesional characteristics, clinical presentation or referral practices specific to each institution. 14 Of the 893 cases, 10.8% could be retrospectively categorised as AUS, almost in line with the MSRSGC recommendation of keeping atypical diagnoses less than 10% of all salivary gland FNA diagnoses.
The cases in the AUS category comprised of a heterogeneous mixture of entities with a 79.6% risk of neoplasm and 30.6% risk of malignancy, higher than the MSRSGC proposed 20% ROM. 14 Other reported rates for AUS from the literature range from 0% to 73.1%, again highlighting the vast differences in salivary gland FNA practices across institutions. 24, 27, 28 Attention to certain features, such as the presence of mucin or a lymphoid population, is warranted when considering an atypical diagnosis. In our study, six cases called AUS were found to be lymphomas on resection, highlighting the importance of using ancillary testing such as flow cytometry to confirm the presence of a lymphoproliferative disorder. Flow cytometric studies, when used in combination with cytology, has been shown to increase diagnostic yield and can also decrease the rate of atypical diagnoses by more than 50%. 28, 29 Additionally, there were five cases of mucoepidermoid carcinoma on follow-up, which showed a mucinous background on FNA. The main limitation of our study lies in its retrospective design.
Bias may have been introduced in retroactively assigning Milan System categorisations to cytological diagnoses, particularly for cases in which the histological follow-up was known. However, at our institution as well as many others, the Milan System has not yet been adopted and thus, retrospective methods continue to be the main mode of investigation. With the recent publication of the MSRSGC and as the Milan System gains traction among cytopathologists, hopefully more prospective data will be available.
| CONCLUSION
In conclusion, this study highlights our institutional experience with salivary gland FNAs and the clinical applicability of the MSRSGC as a tool for risk assessment. Cytology can accurately classify many entities, including diagnostically challenging cases. As the diagnostic criteria set forth by the MSRSGC become well defined and established, diagnostic reproducibility can be maximised, allowing us to better communicate with clinicians and guide them towards appropriate management strategies.
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